ZEN Graphene Solutions Ltd Asset Resilience Ratio

Latest as of December 2024: 5.26%

ZEN Graphene Solutions Ltd asset resilience ratio. ZEN Graphene Solutions Ltd (ZTEK) has an Asset Resilience Ratio of 5.26% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can ZEN Graphene Solutions Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$694.90K
Cash + Short-term Investments

Total Assets

$13.22 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of ZEN Graphene Solutions Ltd (2010–2024)

Asset resilience ratio of ZEN Graphene Solutions Ltd from 2010 to 2024. This chart shows how ZEN Graphene Solutions Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of ZEN Graphene Solutions Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down ZEN Graphene Solutions Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ZEN Graphene Solutions Ltd total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $694.90K 5.26%
Total Liquid Assets $694.90K 5.26%

Asset Resilience Insights

  • Limited Liquidity: ZEN Graphene Solutions Ltd maintains only 5.26% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

ZEN Graphene Solutions Ltd Industry Peers by Asset Resilience Ratio

Compare ZEN Graphene Solutions Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 19.55%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%
Ocumetics Technology Corp
V:OTC
Medical Instruments & Supplies 0.00%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 22.60%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%

ZEN Graphene Solutions Ltd Asset Resilience Ratio by Year (2010–2024)

ZEN Graphene Solutions Ltd asset resilience ratio by year from 2010 to 2024. The table below shows the annual Asset Resilience Ratio data for ZEN Graphene Solutions Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-03-31 13.28% $2.21 Million $16.67 Million +12.84pp
2022-03-31 0.44% $159.84K $35.95 Million --
2018-03-31 0.00% $0.00 $22.22 Million --
2017-03-31 2.69% $613.28K $22.80 Million +1.47pp
2016-03-31 1.22% $262.86K $21.54 Million +0.07pp
2015-03-31 1.15% $237.30K $20.60 Million -4.97pp
2014-03-31 6.12% $1.30 Million $21.29 Million -1.49pp
2013-03-31 7.61% $1.29 Million $16.95 Million -15.08pp
2012-03-31 22.69% $2.56 Million $11.26 Million -47.65pp
2011-03-31 70.34% $8.55 Million $12.15 Million +57.83pp
2010-03-31 12.52% $400.18K $3.20 Million --
pp = percentage points

About ZEN Graphene Solutions Ltd

NASDAQ:ZTEK USA Medical Instruments & Supplies
Market Cap
$60.31 Million
Market Cap Rank
#20969 Global
#4741 in USA
Share Price
$0.56
Change (1 day)
+9.21%
52-Week Range
$0.37 - $1.06
All Time High
$5.70
About

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also… Read more